Portal hosted two partner training visits this week to explore cell engineering tech in life sciences.
Published
Signal category
Presence & Recognition
Quote
“This week, I got to hop on two partner training visits and see our cell engineering tech being applied to wide-ranging cutting-edge ideas in life sciences, in both academia and industry.”
— Xinyi Feng|Portal team
Company
- Industry
- Biotechnology Research
- Location
- Watertown, US
- Company size
- 103 employees
Portal is building the universal infrastructure for cell engineering across drug discovery and cell therapy. Our proprietary mechanical system enables efficient, scalable delivery of RNA, gene editors, probes, and other molecules into hard-to-transfect cells across many cell types and workflows. With more than 100 customer sites including the top 10 pharma, researchers use Portal to run high-throughput, physiologically relevant screens and de-risk targets earlier, while cell therapy developers leverage the platform to multi-engineer cells beyond the limits of viral or electroporation methods. Integrated with leading high-throughput robotics and with GMP manufacturing systems, Portal is powering both next-generation discovery and laying the groundwork for future point-of-care cell therapy manufacturing.
Founded 2023